India and Taiwan roll out domestically produced COVID vaccines despite lack of trial data

Editado por Ed Newman
2021-08-23 15:07:03

Pinterest
Telegram
Linkedin
WhatsApp

India has authorized emergency use of another Indian-made COVID-19 vaccine, after its producer said it prevented symptomatic infections in two-thirds of recipients.

New Delhi, August 23 (RHC)-- India has authorized emergency use of another Indian-made COVID-19 vaccine, after its producer said it prevented symptomatic infections in two-thirds of recipients.  Regulators approved ZyCoV-D even though there’s no publicly available data on its performance in advanced clinical trials.

Meanwhile, in Taiwan, President Tsai Ing-wen has publicly received a shot of the home-grown Medigen vaccine.  Regulators approved the two-dose vaccine last July — though a late-stage clinical trial remains ongoing.
 



Comentários


Deixe um comentário
Todos os campos são requeridos
Não será publicado
captcha challenge
up